	Mechanistic insights from experimental autoimmune encephalomyelitis into immune regulation, autophagy, gut microbiota, blood-brain barrier integrity, and NLRP3 inflammasome-mediated pyroptosis in multiple sclerosis: potential clinical implications. Front Neurosci Zhang SM, Tang WC, Liu FF, Bai QQ, Guo Y, Bai XZ, Wang YF, Ma XY, Pan SJ, Yang YH, Du GQ, Fan H. PMID: 42136986 [PubMed]
	An algorithm to predict intrathecal IgM synthesis in multiple sclerosis patients: optimizing the use of oligoclonal band testing. Adv Lab Med Tortosa-Carreres J, Cubas-Núñez L, Castillo-Villalba J, Forés-Toribio L, Piqueras M, Gasque-Rubio R, Carratalà-Boscà S, Quintanilla-Bordás C, Gorriz-Romero D, Casanova B, Laiz-Marro B, Pérez-Miralles FC. PMID: 42136975 [PubMed]
	Immature CD10(low) blood neutrophils are enriched in people with multiple sclerosis. Front Immunol Garratt LW, White AA, Schofield C, Leffler J, Hart PH, Fabis-Pedrini MJ, Kermode AG, Brüstle A, Trend S. PMID: 42136635 [PubMed - indexed for MEDLINE]
	The correlation between serum markers of oxidative stress and fatigue and related factors in minimally disabled patients with relapsing-remitting multiple sclerosis. Sci Rep Alipour A, Mosaddeghi-Heris R, Darvishi A, Parvaneh S, Talebi M, Taheri N, Talebi M, Naseri A. PMID: 42135428 [PubMed - as supplied by publisher]
	Validation of a new diagnostic ELISA to detect anti-JCV antibodies in serum of patients with multiple sclerosis considering or receiving treatment with natalizumab. Mult Scler Relat Disord Adler F, Andersen M, Bartl T, Derlacz R, Frese MA, Keller T, Schelcher C, Wiegand R. PMID: 42134893 [PubMed - indexed for MEDLINE]
	A tailored cognitive behavioural therapy intervention for depression in those newly diagnosed with multiple sclerosis (ACTION-MS): A randomised, assessor-blinded, active comparator trial. J Affect Disord Kiropoulos LA, Kilpatrick TJ, Kalincik T, Churilov L, Macdonell R, Shuey N, Wijeratne T. PMID: 42134745 [PubMed - as supplied by publisher]
	External validation and improvement of an algorithm that identifies multiple sclerosis relapses in the French national healthcare claims database. Mult Scler Relat Disord Carcaillon-Bentata L, Abouelfath A, Lignot-Maleyran S, Lassalle R, Jové J, Blin P, Berger E, Bourre B, Camdessanche JP, Casez O, Ciron J, David T, De Seze J, Defer G, Doghri I, Santos AD, Hankiewicz K, Heinzlef O, Labauge P, Page EL, Lebrun-Frenay C, Leclancher A, Louapre C, Manchon E, Mathey G, Montcuquet A, Papeix C, Pelletier J, Pottier C, Ruet A, Sarov-Riviere M, Vukusic S, Magy L, Moulin M, Brochet B, Casey R, Leray E, OFSEP Investigators. PMID: 42134166 [PubMed - as supplied by publisher]
	Updated systematic literature review and network meta-analysis of cladribine tablets versus currently approved disease-modifying treatments for active relapsing-remitting multiple sclerosis. Mult Scler Relat Disord Harty GT, Jones M, Maheshwari V, Saipriya J. PMID: 42134165 [PubMed - as supplied by publisher]
	The Effect of Ocrelizumab on Anti-JC Virus Antibody Index. Brain Behav Virupakshaiah A, Gill AJ, Schoeps VA, Wilson E, Wilson J, Do D, Bar-Or A, Jacobs D, Berger JR. PMID: 42133543 [PubMed - indexed for MEDLINE]
	Psychosis in multiple sclerosis-a narrative review of an underestimated, but clinically significant problem. J Neural Transm (Vienna) Olejnik P, Prisco A, Menchetti M, Kasare. PMID: 42133011 [PubMed - as supplied by publisher]
	The Impact of Task-Oriented Training on Health Outcomes in Multiple Sclerosis: A Systematic Review and Meta-Analysis. Am J Phys Med Rehabil Navas-Otero A, Ortiz Rubio A, Raya-Benítez J, Heredia-Ciuró A, Granados-Santiago M, López-López L, Rodríguez-Martínez MDC. PMID: 42132414 [PubMed - as supplied by publisher]
	Eye movement analysis during working memory tasks correlates with cognitive, clinical, and anatomical metrics in multiple sclerosis. Mult Scler J Exp Transl Clin Pardo CF, Fernandez G, Allushi B, Bhaktaram AA, Galleguillos L, Verge D, Pardo G. PMID: 42131773 [PubMed]
	Do apelin and ghrelin play a role in multiple sclerosis? The analysis of patients treated with immunomodulatory therapies. Front Immunol Adamczyk B, Morawiec N, Rakoca M, Sowa A, Sawa K, Adamczyk-Sowa M. PMID: 42131351 [PubMed - indexed for MEDLINE]
	Oxidized mannan-MOG35-55 conjugate as a platform for antigen-specific immune modulation in multiple sclerosis. Front Immunol Mouzaki A, de Lastic AL, Apostolopoulos V, Matsoukas I. PMID: 42131329 [PubMed - indexed for MEDLINE]
	Serum neurofilament light chain and multiple sclerosis prognosis: a systematic review and meta-analysis. Front Immunol Chen Y, Cai M, Lv X. PMID: 42131327 [PubMed - indexed for MEDLINE]
	PRIMUS: a precision medicine platform reusing clinical trials and registry data to support treatment selection in multiple sclerosis. JAMIA Open Demuth S, Faddeenkov I, Paris J, Rousseau O, Baciotti B, Payet M, Casey R, Vukusic S, Doyle S, Jarre G, Vince N, Limou S, De Sèze J, Kerbrat A, Laplaud D, Edan G, Gourraud PA, PRIMUS Consortium. PMID: 42131074 [PubMed]
	Multiple sclerosis diagnosis in south Asia: fundamentals first. Lancet Reg Health Southeast Asia The Lancet Regional Health-Southeast Asia. PMID: 42130678 [PubMed]
	Which medication improves fatigue in patients with multiple sclerosis (MS)?: a systematic review and network meta-analysis. Neurodegener Dis Manag Rastkar M, Ghandchi S, Ghajarzadeh M, Ghajarzadeh M. PMID: 42130400 [PubMed - as supplied by publisher]
	Flip angle in susceptibility-weighted imaging for the diagnosis of multiple sclerosis - Authors' reply. Lancet Neurol Sati P, Barkhof F, Reich DS, Ontaneda D, Rovira À. PMID: 42127925 [PubMed - in process]
	Flip angle in susceptibility-weighted imaging for the diagnosis of multiple sclerosis. Lancet Neurol Sonoda Y, Hagiwara A, Tomizawa Y, Hatano T, Kamagata K. PMID: 42127924 [PubMed - in process]

Articles 1 - 20 / 43999

Page 1 of 2200



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy